BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 1371724)

  • 1. Modified immunoradiometric assay of parathyroid hormone-related protein: clinical application in the differential diagnosis of hypercalcemia.
    Pandian MR; Morgan CH; Carlton E; Segre GV
    Clin Chem; 1992 Feb; 38(2):282-8. PubMed ID: 1371724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The value of the parathyrin-related protein (PTH-RP) in the diagnosis of cancer-associated hypercalcemia].
    Sagarra E; Villabona C; Bonnin R; Moliner R; Merino FJ; Sahún M; Soler J
    Med Clin (Barc); 1995 Oct; 105(12):450-4. PubMed ID: 7490935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parathyroid hormone and parathyroid hormone related protein assays in the investigation of hypercalcemic patients in hospital in a Chinese population.
    Lee JK; Chuang MJ; Lu CC; Hao LJ; Yang CY; Han TM; Lam HC
    J Endocrinol Invest; 1997; 20(7):404-9. PubMed ID: 9309539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunochemiluminometric and immunoradiometric determinations of intact and total immunoreactive parathyrin: performance in the differential diagnosis of hypercalcemia and hypoparathyroidism.
    Endres DB; Villanueva R; Sharp CF; Singer FR
    Clin Chem; 1991 Feb; 37(2):162-8. PubMed ID: 1993319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Determination of intact parathyroid hormone in patients with calcium metabolism disorders].
    Birkeland KI; Falch JA; Gautvik KM; Gjestvang FT; Holst N; Haug E
    Tidsskr Nor Laegeforen; 1991 Jun; 111(15):1840-4. PubMed ID: 1853314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parathyroid hormone-related protein and hypercalcemia.
    Rankin W; Grill V; Martin TJ
    Cancer; 1997 Oct; 80(8 Suppl):1564-71. PubMed ID: 9362423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of assays for parathyroid-hormone-related protein in investigation of hypercalcaemia.
    Ratcliffe WA; Hutchesson AC; Bundred NJ; Ratcliffe JG
    Lancet; 1992 Jan; 339(8786):164-7. PubMed ID: 1346019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia.
    Nussbaum SR; Zahradnik RJ; Lavigne JR; Brennan GL; Nozawa-Ung K; Kim LY; Keutmann HT; Wang CA; Potts JT; Segre GV
    Clin Chem; 1987 Aug; 33(8):1364-7. PubMed ID: 3608153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance and diagnostic application of a two-site immunoradiometric assay for parathyrin in serum.
    Ratcliffe WA; Heath DA; Ryan M; Jones SR
    Clin Chem; 1989 Sep; 35(9):1957-61. PubMed ID: 2776325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoradiometric assay of parathyrin with polyclonal and monoclonal region-specific antibodies.
    Bouillon R; Coopmans W; Degroote DE; Radoux D; Eliard PH
    Clin Chem; 1990 Feb; 36(2):271-6. PubMed ID: 1689222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical performance of parathyroid hormone immunometric assays.
    Kao PC; van Heerden JA; Grant CS; Klee GG; Khosla S
    Mayo Clin Proc; 1992 Jul; 67(7):637-45. PubMed ID: 1434896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and laboratory studies of a new immunoradiometric assay of parathyroid hormone-related protein.
    Fraser WD; Robinson J; Lawton R; Durham B; Gallacher SJ; Boyle IT; Beastall GH; Logue FC
    Clin Chem; 1993 Mar; 39(3):414-9. PubMed ID: 8448850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma parathyroid hormone related-protein levels in patients with cancer, normocalcemic and hypercalcemic.
    Segura Domínguez A; Andrade Olivié MA; Rodríguez Sousa T; Terrón Alvarez ML; Rodríguez Perez D; Alvarez Novoa R; García-Mayor RV
    Clin Chim Acta; 1996 Jan; 244(2):163-72. PubMed ID: 8714434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent hypercalcemia due to ectopic production of parathyroid hormone-related protein and intact parathyroid hormone in a single patient with multiple malignancies.
    Eid W; Wheeler TM; Sharma MD
    Endocr Pract; 2004; 10(2):125-8. PubMed ID: 15256329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma PTH and PTH-rP levels and clodronate therapy in cancer patients with hypercalcemia.
    Su RJ; Chang CC; Tsai KS
    J Formos Med Assoc; 1993 Nov; 92(11):977-82. PubMed ID: 7910069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoassays for parathyroid hormone 1-84 in the diagnosis of hyperparathyroidism.
    Nussbaum SR; Potts JT
    J Bone Miner Res; 1991 Oct; 6 Suppl 2():S43-50; discussion S61. PubMed ID: 1722383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro stability of endogenous parathyroid hormone-related protein in blood and plasma.
    Hutchesson AC; Hughes SV; Bowden SJ; Ratcliffe WA
    Ann Clin Biochem; 1994 Jan; 31 ( Pt 1)():35-9. PubMed ID: 7512317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parathyroid hormone-related protein: elevated levels in both humoral hypercalcemia of malignancy and hypercalcemia complicating metastatic breast cancer.
    Grill V; Ho P; Body JJ; Johanson N; Lee SC; Kukreja SC; Moseley JM; Martin TJ
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1309-15. PubMed ID: 1955513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conventional and new diagnostic applications of a two-site immunochemiluminometric assay for parathyroid hormone.
    Minisola S; Scarnecchia L; Romagnoli E; Carnevale V; Pacitti MT; Scarda A; Rosso R; Mazzuoli GF
    J Endocrinol Invest; 1992; 15(7):483-9. PubMed ID: 1447486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical utility of an immunoradiometric assay for parathyroid hormone (1-84) in primary hyperparathyroidism.
    Silverberg SJ; Gao P; Brown I; LoGerfo P; Cantor TL; Bilezikian JP
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4725-30. PubMed ID: 14557447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.